Opening bell, April 10, 2026: S&P 500 climbs to 6,837.97 as CPI relief rally meets ceasefire optimism

NEW YORK, April 10, 2026 — Wall Street’s opening bell on Friday rang in a measured but broadly positive session, as a consumer price index report that landed squarely within consensus estimates delivered the clarity investors had been awaiting since the onset of the U.S.-Iran conflict. The S&P 500 climbed to 6,837.97 in early trading — gaining approximately 0.20% shortly after the open — while the Nasdaq Composite advanced to 22,951.16, up 0.56%, buoyed by semiconductor and technology names responding to eased rate-expectations pressure. The Dow Jones Industrial Average, by contrast, slipped roughly 221 points, or 0.5%, as defensive and cyclical names pulled back modestly. The VIX, Wall Street’s closely watched fear gauge, retreated to approximately 19.12, a level consistent with historical norms and a sharp step down from the elevated readings that characterised the market during peak Iran-war tensions.

The macro backdrop that greeted traders at 9:30 AM ET was defined by two concurrent forces: the first confirmed reading of March inflation since the outbreak of hostilities between the United States and Iran, and lingering optimism around the fragile two-week ceasefire and the prospect of weekend diplomatic talks in Islamabad. For a market that had spent weeks pricing in geopolitical tail risk, the combination of in-line data and cautious diplomatic progress provided enough of a footing for risk assets to extend the week’s recovery.

March CPI: relief, not resolution

The Bureau of Labor Statistics released the March 2026 Consumer Price Index report at 8:30 AM ET, and the headline number — while elevated — did not deliver the upside shock that had been the market’s deepest fear. Headline CPI rose 0.9% month-over-month and 3.3% year-over-year, marking the highest annual rate since May 2024 but landing precisely in line with the Wall Street consensus. Core CPI, which strips out volatile food and energy components, rose a more restrained 0.2% month-over-month and 2.6% year-over-year — a figure that came in below some estimates and offered a measure of reassurance to investors focused on the underlying trend.

The driver of the hot headline number was unambiguous: energy. The index for energy surged 10.9% in March, led by a 21.2% spike in gasoline prices — a direct consequence of the disruption to oil flows through the Strait of Hormuz during the period of active conflict. Shelter costs also rose, as did prices for airfare, apparel, and new vehicles. Medical care, personal care, and used vehicles declined. The rapid acceleration from February’s figures of +0.3% MoM and +2.4% YoY underscores the velocity with which the Iran war’s commodity shock transmitted through the consumer price complex. For context, this is the first inflation print of the Iran war era, and despite the severity of the monthly gain, the fact that it matched forecasts was sufficient to trigger a buy-the-news response in equities.

The Federal Open Market Committee’s position heading into this release was already hawkish. FOMC minutes released this week confirmed that the vast majority of Fed officials warned inflation is running persistently above target, and rate hikes have returned to the discussion. Friday’s CPI data, while not benign, did not materially change that calculus — core’s moderation offers the Fed some room to remain data-dependent rather than reactive.

Opening bell standout mover: UnitedHealth Group (NYSE: UNH)

Among the large-cap catalysts defining this week’s tape, no single name carried more weight than UnitedHealth Group (NYSE: UNH). On Friday, April 10, UNH traded within an intraday range of $303.88 to $307.89, consolidating around the $306 level after a historic week of recovery. The stock closed on April 9 at $306.91, and Friday’s session volume of approximately 5.74 million shares ran below the 10-day average of 9.04 million, consistent with a consolidation phase rather than a continuation of directional momentum.

The catalyst for UNH’s week-defining move was the April 6, 2026, announcement from the Centers for Medicare and Medicaid Services (CMS), which finalised a 2.48% net average rate increase for Medicare Advantage plans for the 2027 calendar year. That figure represented a dramatic improvement over the near-flat 0.09% increase proposed in January, a proposal that had sent managed care stocks into a sustained downtrend throughout the first quarter. In total industry terms, the finalised rate is expected to inject more than $13 billion in additional funding into the Medicare Advantage programme — a figure that analysts estimate translates to approximately $4 billion in additional revenue visibility for UNH’s 2027 fiscal year.

The market’s response was swift. UNH shares surged 9.4% on Tuesday, April 7, advancing from a Monday close of $281.41 to close at $307.73. That single-session gain — exceptional for a mega-cap healthcare name with a market capitalisation of approximately $278 billion — reflected more than a year of accumulated pessimism unwinding against a more favourable regulatory backdrop. The stock had traded as low as $234.60 within its 52-week range, against a 52-week high of $606.36. For additional context on the week’s catalyst chain, see PreMarket Daily’s earlier coverage of the Friday roundup on the week’s key macro and earnings developments.

Supporting the CMS catalyst, Raymond James upgraded UNH to Outperform with a $330 price target in early April, citing improving margin visibility at the Optum Health division. Bernstein subsequently lifted its price target to $411, citing approximately 25 basis points of margin improvement above prior estimates and a 1.4% boost to its 2027 EPS outlook. Bank of America raised its price target to $337 while maintaining a Neutral rating. The Wall Street consensus now stands at 22 Buy ratings, 5 Hold ratings, and 2 Sell ratings, with a median price target of $357.81.

The broader managed care sector moved in sympathy. Humana (NYSE: HUM) surged approximately 12.2% on the rate news, with shares rising to roughly $198. CVS Health climbed nearly 5%, Elevance Health gained 3–4%, and Evolent Health rose approximately 11%. The sector-wide re-rating reflected investors’ view that the CMS decision represents a structural improvement in the reimbursement environment, not merely a one-time relief trade. Full detail on the CPI data and its market impact is available via CNBC.

UNH’s April 21 Q1 2026 earnings report looms as the next major inflection point for the stock. Analysts expect adjusted earnings per share of approximately $6.69 for the quarter, representing an 8% decline from the same period a year ago, with revenue forecast at roughly $109.58 billion. Options markets are pricing in a move of approximately 9% in either direction following the release — a reflection of the residual uncertainty around medical cost ratios, membership trends, and the practical impact of the improved reimbursement environment. Full investor relations information is available on the UnitedHealth Group investor relations page.

Volume and price action analysis

Friday’s opening-hour price action was characterised by a divergence between index-level optimism and sector rotation beneath the surface. The Nasdaq’s outperformance relative to the Dow — the Nasdaq gaining 0.56% versus the Dow slipping 0.5% — reflected a technology-led bid driven by eased rate expectations following core CPI’s benign 0.2% monthly reading. Semiconductor names including Nvidia and Broadcom contributed to the Nasdaq’s advance, continuing the AI infrastructure theme that has underpinned tech’s relative strength throughout the ceasefire-driven recovery week.

The S&P 500’s position near 6,837.97 placed it comfortably above its 200-day moving average of 6,655 — a technically significant level that the index was targeting as of Wednesday’s open. The 50-day moving average of 6,771 represents the next reference point for momentum traders. The Nasdaq-100 (NDX) opened above its 200-day moving average of 24,472, with its 50-day average of 24,720 serving as the near-term upside target. The S&P 500 is on pace for a weekly gain of more than 3%, which would represent its best weekly performance since November.

Treasury yields also provided context for equity positioning. The 10-year note yield stood at approximately 4.29%, reflecting an earlier 10 basis-point drop tied to easing energy price concerns as the ceasefire held. Brent crude remained elevated near $100 per barrel — a persistent reminder that the geopolitical risk premium, while partially unwound, has not been fully extinguished. The VIX at 19.12 — down approximately 1.90% on the session — suggests the market is paying materially less for near-term downside protection than at the peak of the conflict, but has not yet returned to the complacency levels observed before the Iran war began. For more on recent speculative flows and intraday volume dynamics, see PreMarket Daily’s earlier analysis of mega-cap volatility signals.

Energy stocks, which had surged as much as 34% in 2026 on the back of rising oil prices, faced modest headwinds as the ceasefire narrative supported expectations of a return of Hormuz traffic and eased supply constraints. Some defensive sectors also lagged as investors rotated into growth names benefiting from the lower rate-expectations impulse. Financials and materials names showed mixed early performance.

What to watch in the first hour

Several variables are likely to determine the direction of the tape through Friday’s midday session. First, investors are monitoring any fresh signals from the U.S.-Iran ceasefire negotiations, with weekend diplomatic talks in Islamabad serving as the next major catalyst for geopolitical positioning. President Trump has continued to press Iran on the Strait of Hormuz, where traffic remains thin despite the two-week truce. Any indication of deteriorating talks — or conversely, a constructive communiqué from Islamabad — could move oil prices sharply, with a corresponding ripple through equities and bond yields.

Second, the preliminary April University of Michigan Consumer Sentiment survey was also scheduled for release Friday morning, providing a timely read on household confidence against the backdrop of surging gasoline prices and elevated headline inflation. Sentiment data at this juncture carries additional weight as a signal for consumer-facing sectors — discretionary, staples, and travel names — all of which have been navigating the war-era cost environment in different ways.

Third, UNH’s price action in the first hour will be closely tracked by healthcare sector participants. With the stock consolidating near $306 and Q1 earnings less than two weeks away, institutional positioning is likely already shifting in anticipation of the April 21 report. Options-implied volatility of approximately 9% post-earnings suggests that traders are not treating the CMS rate uplift as a full resolution of the company’s operational challenges. Medical cost ratios, Optum membership trends, and any revised full-year EPS guidance — currently targeting above $17.75 — will be the decisive metrics on the earnings call.

Fourth, next week’s earnings calendar adds further urgency to this week’s positioning. JPMorgan Chase, Wells Fargo, and other major banks are due to report Q1 results, followed by Netflix — a schedule that makes Friday’s session a de facto pre-positioning window for institutional accounts managing sector exposure across financials, technology, and healthcare simultaneously. For a full preview of next week’s earnings and macro calendar, see PreMarket Daily’s Friday roundup.

The broader context framing all of these first-hour variables is a market that has covered significant ground in a short period of time. From the depths of the Iran-war risk premium to this week’s relief rally, the S&P 500 has recovered sharply — putting it within approximately a tenth of a percentage point of erasing all of 2026’s losses. Whether that recovery proves durable hinges on variables that remain genuinely unresolved: the longevity of the ceasefire, the pace of Hormuz traffic normalisation, and the Federal Reserve’s willingness to maintain its current data-dependent posture as inflation — while no longer accelerating unexpectedly — remains structurally above the 2% target. Friday’s opening hour is as much about stress-testing those assumptions as it is about absorbing the CPI data itself.